Empresa biOasis Technologies Inc Toronto S.E.
Acciones
BTI
CA09064N1033
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
CAD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Diagnosis and Treatment of Neurological Diseases and Disorders
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -99,07 % |
Ventas por región
CAD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -99,07 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Deborah Rathjen
CEO | Chief Executive Officer | - | 21/09/17 |
Dave Jenkins
DFI | Director of Finance/CFO | - | 01/07/21 |
Mei Mei Tian
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/12 |
Graeme Dick
IRC | Investor Relations Contact | - | 01/11/11 |
Christopher Lowe
SEC | Corporate Secretary | 56 | 03/10/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
John Hemeon
BRD | Director/Board Member | 59 | - |
David Wurzer
BRD | Director/Board Member | 65 | 27/07/18 |
Deborah Rathjen
CEO | Chief Executive Officer | - | 21/09/17 |
Director/Board Member | 63 | 01/06/18 | |
John E. Curran
BRD | Director/Board Member | - | 27/07/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 79 414 015 | 77 784 778 ( 97,95 %) | 0 | 97,95 % |
Información de la empresa
![Dirección biOasis Technologies Inc(BTI)](https://cdn.zonebourse.com/static/address/2941086.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,35 % | 44,87 mil M | |
-10,69 % | 37,8 mil M | |
+40,83 % | 37,61 mil M | |
+28,84 % | 31,32 mil M | |
-8,44 % | 27,4 mil M | |
+12,09 % | 26,32 mil M | |
+41,41 % | 14,07 mil M | |
+32,54 % | 12,5 mil M | |
-6,69 % | 11,23 mil M |